Granules India Inks Deal To Set Up JV In China

Search by Type

Report Charts News

Search by Company

Code Company name

Granules India Inks Deal To Set Up JV In China - ResearchInChina

Date:2007-03-08 Source:jinxiajinxia Text Size:

Granules India announced that the company signed an agreement with Hubei Biocause Heilen Pharmaceutical, China, for setting up of a joint venture company in China.

The company further stated that the joint venture company christened Hubei Granules Biocause Pharmaceutical Co has been registered and would now become operational. The JV Company will manufacture Ibuprofen API presently.

Welcome to our website. This service is open to member only.

Registration

Contact our customer service team
Tel: 86-10-82600828, 82600893
Fax: 86-10-82601570
Email: report@researchinchina.com

RelatedReport

China Animal Vaccine Industry Report, 2010-20112011-08-18
China Human Vaccine Industry Report, 2010-20112011-05-27
China Pharmaceutical Chain Industry Report, 20102010-12-14
China Chemical Pharmaceutical Industry Report, 2009-20102010-12-08
China Vaccine Industry Report, 2009-20102010-09-26
China Animal Vaccine Industry Report, 2009-20102010-06-25
China Pharmaceutical Industry Statistics, 2000-20092010-02-09
China Antibiotic Market Report, 2008-20092009-12-25

RelatedNews

AstraZeneca relies on partners2011-09-26
Medtronic opens orthopedic R&D center with Weigao2011-09-16
Sinopharm posts huge increase in profits2011-09-01
Fosun Pharmaceutical Earnings Up 57%2011-08-31
Yunnan Baiyao H1 Net Profits to CNY564mn, Growing 30.8%2011-08-23
Bohai Pharmaceuticals Group, Inc. (BOPH) Expands Presence in Chinese TCM Market with Acquisition of Yantai Tianzheng2011-08-11
Guangzhou Pharmaceutical Launches Online Medicine Store2011-08-11
Southwest Pharma H1 Earnings Up 43%2011-08-11